Marc Ditmarsch

5PUBLICATIONS
6CO-AUTHORS
Predictive and prognostic markersPharmaceutical delivery technologiesCardiology (incl. cardiovascular diseases)Proteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 25, 2026
Obicetrapib and lipoprotein(a) levels in patients at high cardiovascular risk: a pooled analysis of trials.

|Oct 19, 2024
Obicetrapib exhibits favorable physiochemical and pharmacokinetic properties compared to previous cholesteryl ester transfer protein inhibitors: An integrated summary of results from non-human primate studies and clinical trials.

Stephen J Nicholls, Adam J Nelson, John J P Kastelein

|Oct 29, 2022
Comparison of low-density lipoprotein cholesterol equations in patients with dyslipidaemia receiving cholesterol ester transfer protein inhibition.

Seth S Martin, Marc Ditmarsch, Mark Simmons

|Dec 01, 2021
Cholesteryl ester transfer protein inhibitors: from high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?

Nick S Nurmohamed, Marc Ditmarsch, John J P Kastelein

Pageof 1

Frequent Collaborators

1 joint publications

Nick S Nurmohamed

1 joint publications

John J P Kastelein

1 joint publications

Seth S Martin

1 joint publications

Fotios Barkas